TradeUP (NASDAQ:UPTD) announced this morning that it has closed its combination with Estrella Biopharma and its shares and warrants will begin trading on the Nasdaq under the symbols “ESLA” and “ESLAQ” on October 2.
This will be the first time that TradeUp sub-unit’s will split into shares and their accompanied 1/2 warrants. The SPAC secured shareholder approval for the deal way back on July 31, but TradeUP has spent the past two months securing additional committed financing for the combination.
Estrella is to receive $23.1 million in gross proceeds in the end made up of $10 million in PIPE cash, $9.75 million from a preferred offering and about $300,000 in debt, according to the parties’ press release.
That leaves about $3.05 million in equity coming from TradeUp shares. The SPAC saw 98% redemptions reduce its trust to about $829,703 in the final vote, but it also issued 250,000 TradeUp shares to White Lion Capital as a part of a its commitments in a common stock agreement that may see it purchase up to $50 million in stock post-close.
TradeUp initially announced its $398 million combination with Estrella Biopharma in October 2022. Emeryville, California-based Estrella is developing three potential cancer therapies aimed at improving the effectiveness of T-cell treatments.
In March, it gained FDA clearance to start Phase I/II trials for its EB-103 drug candidate, which uses its CD19 t-cell therapy to combat b-cell lymphoma.
ADVISORS
- US Tiger Securities, Inc. has acted as financial advisor to TradeUP.
- Robinson & Cole LLP acted as legal advisor to TradeUP.
- Winston & Strawn LLP acted as legal advisor to Estrella.
FG Merger III Corp. filed for a $150 million IPO yesterday afternoon, marking the third SPAC to file on Wednesday. Similar to Blue Room (NASDAQ:IBLUU), which filed its $200 million IPO yesterday morning, FG Merger III intends to focus its search for a target business in the financial services industry in North America. Notably, FG...
10X Capital Venture Acquisition Corp. II (NASDAQ:VCXA) announced that it has completed its business combination with African Agriculture after shareholders approved the deal at a special meeting held on December 5. In connection with the meeting, 10X II received redemption requests for 1,857,033 Class A ordinary shares, representing 98.7% in aggregate redemptions since 10X II’s...
At the SPAC of Dawn The latter half of 2023 has largely told a story of retrenchment in the SPAC market as much of the excess in the domain has found itself terminating and liquidating. But, the increase in outgoing has not completely canceled out the boom in incoming as three new SPACs filed to...
TechyBird Acquisition Corp. (NASDAQ:TKBD) filed for a $60 million IPO today, putting it in line to become the second 2023 IPO from an underwriter that is relatively new to the SPAC space. That underwriter, Spartan Capital Securities, brought Aimei Health Technology (NASDAQ:AFJK) to market last week with similar terms as this new member to its...
Blue Room Acquisition Corp. (NASDAQ:IBLUU) submitted its S-1 filing this morning for a $200 million IPO. The new SPAC has set its sights on targets in the financial sector, ranging in market value between $250 million and $500 million, and primarily situated in the U.S. Its primary objective is to identify an innovative company leveraging...